Sema4 Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:SMFR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Nov 22BuyUS$100,000Katherine StuelandIndividual185,185US$0.54
20 May 22BuyUS$192,480Eric SchadtIndividual100,000US$1.92
29 Apr 22BuyUS$45,750,000Corvex Management LPCompany11,437,500US$4.00
29 Apr 22BuyUS$45,750,000Casdin Capital, LLCCompany11,437,500US$4.00
29 Apr 22BuyUS$10,000,000Blackstone Inc.Company2,500,000US$4.00
29 Apr 22BuyUS$25,000,000Mount Sinai School Of Medicine, Endowment ArmCompany6,250,000US$4.00
28 Apr 22SellUS$2,643Daniel ClarkIndividual1,212US$2.18
28 Apr 22SellUS$78,274Eric SchadtIndividual35,899US$2.18
28 Apr 22SellUS$3,118Karen WhiteIndividual1,430US$2.18
28 Apr 22SellUS$3,688Anthony PrenticeIndividual1,691US$2.18
06 Apr 22SellUS$3,737Isaac RoIndividual1,284US$2.91
28 Jan 22SellUS$4,298Daniel ClarkIndividual1,512US$2.84
28 Jan 22SellUS$82,667Eric SchadtIndividual29,100US$2.84
28 Jan 22SellUS$5,046Karen WhiteIndividual1,776US$2.84
28 Jan 22SellUS$19,026Kareem SaadIndividual6,697US$2.84
28 Jan 22SellUS$5,743Anthony PrenticeIndividual2,021US$2.84
14 Jan 22BuyUS$25,000,000Mount Sinai School Of Medicine, Endowment ArmCompany6,250,000US$4.00

Insider Trading Volume

Insider Buying: SMFR insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SMFR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,596,4671.2%
Private Companies10,993,7502.8%
VC/PE Firms27,656,9937.2%
General Public37,974,2229.8%
Public Companies80,000,00020.7%
Institutions225,573,69858.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 60.3%.


Top Shareholders

Top 25 shareholders own 86.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.46%
Mount Sinai School Of Medicine, Endowment Arm
94,605,473$37.7m0%66.9%
20.68%
OPKO Health, Inc.
80,000,000$31.9m0%no data
7.15%
Blackstone Inc.
27,656,993$11.0m0%0.04%
4.39%
Deerfield Management Company, L.P. Series C
16,973,488$6.8m-9.95%0.23%
4.25%
Casdin Capital, LLC
16,437,500$6.6m0%0.55%
4.12%
Corvex Management LP
15,937,500$6.4m0%0.35%
3.47%
BlackRock, Inc.
13,432,597$5.4m5.52%no data
2.84%
CMLS Holdings LLC
10,993,750$4.4m0%no data
2.41%
The Vanguard Group, Inc.
9,306,795$3.7m0.48%no data
2.17%
Oracle Investment Management, Inc.
8,403,926$3.4m27.62%2.97%
1.46%
Marshall Wace LLP
5,650,286$2.3m14.94%0.01%
1.43%
Third Point LLC
5,545,000$2.2m0%0.04%
1.29%
Perceptive Advisors LLC
5,000,000$2.0m0%0.07%
1.04%
Geode Capital Management, LLC
4,030,405$1.6m-0.29%no data
0.9%
State Street Global Advisors, Inc.
3,492,186$1.4m5.97%no data
0.88%
Decheng Capital LLC
3,418,929$1.4m0%0.58%
0.58%
Deutsche Asset & Wealth Management
2,256,028$900.2k-0.47%no data
0.45%
T. Rowe Price Group, Inc.
1,728,304$689.6k2.06%no data
0.44%
Charles Schwab Investment Management, Inc.
1,715,153$684.3k4.63%no data
0.41%
James Coffin
1,597,524$637.4k0%no data
0.4%
Northern Trust Global Investments
1,531,512$611.1k-0.5%no data
0.35%
Zweig-DiMenna Associates, Inc.
1,339,883$534.6k4.28%0.12%
0.29%
Weiss Multi-Strategy Advisers LLC
1,132,873$452.0k0%0.01%
0.29%
Goldman Sachs Group, Investment Banking and Securities Investments
1,131,108$451.3k2824.42%no data
0.28%
Gagnon Securities LLC
1,093,068$436.1k-42.43%0.11%